Homozygous Mutations in TBC1D23 Lead to a Non-degenerative Form of Pontocerebellar Hypoplasia
Isaac Marin‐Valencia(Icahn School of Medicine at Mount Sinai), Joseph G. Gleeson(Children’s Institute), Maha S. Zaki(National Water Research Center), Mariam Al‐Mureikhi(Hamad Medical Corporation), Anne Gregor(University of Bern), Mahmoud Y. Issa(National Research Centre), Frank Baas(Leiden University Medical Center), Sara A. Wirth(University of California San Diego), Tawfeg Ben‐Omran(Qatar Airways (Qatar)), Andreas Gerondopoulos(University of Oxford), Susanne Roosing(Radboud University Nijmegen), Alicia Guemez‐Gamboa(Northwestern University), Başak Rosti(Howard Hughes Medical Institute), Francis A. Barr(University of Oxford), Ercan Demir(Gazi University), Damir Musaev(Yale University), Valentina Stanley(Children’s Institute), Bart Appelhof(Leiden University Medical Center)
Cited by 61
Related Papers
Polo-like kinases and the orchestration of cell division
|Nature Reviews Molecular Cell Biology|2004|1.1k
Phase III Trial of Gemcitabine Plus Cisplatin Versus Cisplatin Alone in Patients With Locally Advanced or Metastatic Non–Small-Cell Lung Cancer
|Journal of Clinical Oncology|2000|719
De novo somatic mutations in components of the PI3K-AKT3-mTOR pathway cause hemimegalencephaly
|Nature Genetics|2012|696
The human multidrug resistance-associated protein MRP is a plasma membrane drug-efflux pump.
|Proceedings of the National Academy of Sciences|1994|691